StockData
Haemonetics Corp logo

Haemonetics Corp (HAE) bonds

HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3073% above fair value
$120.92−0.42 (-0.35%)

Close on Nov 17, 2026Market cap $5.50BP/E 59.0Yield –

Debt

Borrowings on the balance sheet, Jun 27, 2026

Total debt
$1.17B
$4.96M due within a year
Net debt
$950.77M
After $223.38M of cash
Implied interest rate
1.58%
FY2026 interest ÷ average debt
Interest coverage
8.1×
FY2026 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Mar 28, 2026

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Haemonetics's 10-Q for the period ended Jun 27, 2026

IssueCouponMaturesAmount issuedCarrying value
Convertible Senior Notes Due 2029
Convertible at $117 a share
2.50%2029$700.00M$689.60M
2024 Revised Credit Facilities––$250.00M–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeDrawn
Revolving credit facility–$250.00M

See a number that looks wrong?